PHEMEXPRO

PHEMEXPRO is a broker that entered the market in October 2025, registered in the United Kingdom under the name PHEMEXPRO. Its registered address, however, is located in Great Neck, New York, USA, at 11 Grace Avenue, Suite 108. This discrepancy between the country of registration and the physical address is an early point of caution for prospective traders.

According to our records, the broker was founded very recently, on 20 October 2025, which means it has no track record in the industry. The lack of operational history makes it difficult to assess the broker's reliability or performance. Traders should be aware that new entities often carry higher risks due to unproven infrastructure and limited client feedback.

Our checks with official regulatory bodies indicate that PHEMEXPRO does not hold any valid licence from a financial regulator. The company is not authorised by the UK's Financial Conduct Authority (FCA), nor by any other recognised regulator such as CySEC, FSA Seychelles, or any other authority. This is a significant red flag, as unregulated brokers operate outside the protections of mandatory client fund segregation, compensation schemes, and independent dispute resolution.

FXCanary's scam risk score for PHEMEXPRO stands at 57 out of 100, categorised as 'Elevated'. This score reflects the absence of regulatory oversight, the very short operational history, and the lack of verifiable information about the broker's practices. While a moderate score does not automatically imply fraud, it signals that traders should exercise extreme caution and conduct thorough due diligence before any commitment.

PHEMEXPRO offers three tiered account levels designed to cater to different deposit sizes. The entry-level account, Level 1, requires a minimum deposit of $60, making it accessible to retail traders with small capital. Level 2 demands a minimum deposit of $5,000, while Level 3 requires $10,000. Notably, the broker does not specify maximum leverage for any of these account types, leaving a critical risk parameter undisclosed.

The tiered structure suggests the broker aims to attract both small and larger traders. However, without details on spreads, commissions, or trading conditions per tier, it is impossible to assess the true cost of trading. The absence of leverage information is particularly concerning, as it can expose traders to unexpectedly high risk.

Our known facts do not list the specific financial instruments offered by PHEMEXPRO. The broker's website, which we have not independently verified due to inconsistent claims, mentions CFD trading on forex, stocks, indices, commodities, and cryptocurrencies. However, since we cannot rely on those claims, we must state that no confirmed instrument list is available from trusted sources.

Similarly, no information is provided about trading platforms, such as MetaTrader or proprietary software. The lack of clear data on tradable assets and technology further clouds the broker's transparency. Traders seeking a well-defined offering would be advised to look elsewhere.

Given the elevated risk score, unregulated status, and minimal verifiable information, PHEMEXPRO is not suitable for the majority of retail traders. The broker may appeal to experienced traders who are willing to accept high risk in exchange for potentially unverified benefits, but this would be speculative at best.

The absence of regulatory protections means that clients have no recourse through authorities in the event of disputes or financial loss. Therefore, risk-averse traders and those requiring a secure trading environment should avoid this broker entirely. Only those with a high-risk tolerance and a willingness to lose their entire deposit might consider it, and even then, only after extensive further research.

PHEMEXPRO presents itself as a newly established broker with unverified claims. The known facts paint a picture of a company with a short history, no valid regulation, and incomplete information on key trading parameters. FXCanary's elevated risk score underscores these concerns.

In our assessment, until such time as the broker provides verifiable regulatory licences and transparent trading conditions, it should be approached with the highest caution. The lack of independent reviews and limited public information only add to the uncertainty. Traders are strongly advised to prioritise regulated alternatives with proven track records.